[go: up one dir, main page]

KR840007437A - 항생제 a 51568 인자 a 및 b의 제조방법 - Google Patents

항생제 a 51568 인자 a 및 b의 제조방법 Download PDF

Info

Publication number
KR840007437A
KR840007437A KR1019830006026A KR830006026A KR840007437A KR 840007437 A KR840007437 A KR 840007437A KR 1019830006026 A KR1019830006026 A KR 1019830006026A KR 830006026 A KR830006026 A KR 830006026A KR 840007437 A KR840007437 A KR 840007437A
Authority
KR
South Korea
Prior art keywords
antibiotic
factors
preparation
factor
separating
Prior art date
Application number
KR1019830006026A
Other languages
English (en)
Other versions
KR860001497B1 (ko
Inventor
마린 휀 마빈 (외 1)
Original Assignee
아더 알·웨일
일라이 릴리 앤드 캄파니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 아더 알·웨일, 일라이 릴리 앤드 캄파니 filed Critical 아더 알·웨일
Publication of KR840007437A publication Critical patent/KR840007437A/ko
Application granted granted Critical
Publication of KR860001497B1 publication Critical patent/KR860001497B1/ko
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/365—Nocardia
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

내용 없음.

Description

항생제 A 51568 인자 A 및 B의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제1도는 항생제 A 51568 인자 A의 적외선 흡수스펙트럼을 나타내는 도.

Claims (6)

  1. 항생효력을 나타내는 실제적인 양이 생산될때까지 침수호기성 발효조건하 탄소, 질소 및 무기염류의 동화성원을 함유하는 배양배지에서 노카르디아 오리엔탈리스 NRRL 15232(1983년 12월 5일, 한국종균협회에 기탁번호 KFCC-10069로 기탁됨), 또는 그의 A 51568-생산 돌연변이 균주 또는 변형균주를 배양시킴을 특징으로 하여, 일반식(I)의 항생제를 제조하는 방법.
  3. 여기서 n은 1 또는 2이다.
  4. 제1항에 있어서, 배양배지로부터 A 51568 인자 A 항생제를 분리시키는 공정을 포함하는 방법.
  5. 제1항에 있어서, 배양배지로부터 A 51568 인자 B 항생제를 분리시키는 공정을 포함하는 방법.
  6. ※ 참고사항:최초출원 내용에 의하여 공개하는 것임.
KR1019830006026A 1982-12-20 1983-12-20 항생제 a51568 인자 a 및 b의 제조방법 Expired KR860001497B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US45088082A 1982-12-20 1982-12-20
US450,880 1982-12-20
US450880 1982-12-20

Publications (2)

Publication Number Publication Date
KR840007437A true KR840007437A (ko) 1984-12-07
KR860001497B1 KR860001497B1 (ko) 1986-09-27

Family

ID=23789893

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019830006026A Expired KR860001497B1 (ko) 1982-12-20 1983-12-20 항생제 a51568 인자 a 및 b의 제조방법

Country Status (24)

Country Link
EP (1) EP0112184B1 (ko)
JP (2) JPS59118798A (ko)
KR (1) KR860001497B1 (ko)
AT (1) ATE42571T1 (ko)
AU (1) AU563466B2 (ko)
CA (1) CA1214413A (ko)
DD (1) DD210709A1 (ko)
DE (1) DE3379735D1 (ko)
DK (1) DK167688B1 (ko)
EG (1) EG16163A (ko)
ES (1) ES528197A0 (ko)
FI (1) FI834594L (ko)
GB (1) GB2132207B (ko)
GR (1) GR78784B (ko)
HK (1) HK72088A (ko)
HU (1) HU192971B (ko)
IE (1) IE56382B1 (ko)
IL (1) IL70441A (ko)
NZ (1) NZ206592A (ko)
PH (1) PH20198A (ko)
PT (1) PT77810A (ko)
RO (1) RO87735A2 (ko)
SU (1) SU1194285A3 (ko)
ZA (1) ZA839269B (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0159180B1 (en) * 1984-04-16 1989-08-09 Eli Lilly And Company Improvements in and relating to antibiotics m43a, m43b, m43c and m43d
IL78597A0 (en) * 1985-04-25 1986-08-31 Lilly Co Eli Novel glycopeptide derivatives
JP2577133B2 (ja) * 1989-11-27 1997-01-29 スティフティング フォール ド テフニスヘ ウェッテンスハッペン 船舶のプロペラ
RU2633511C1 (ru) * 2016-06-29 2017-10-12 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт по изысканию новых антибиотиков имени Г.Ф. Гаузе" Штамм Amycolatopsis orientalis - продуцент антибиотика диметилванкомицина и способ получения антибиотика

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4322343A (en) * 1980-12-18 1982-03-30 Eli Lilly And Company Pseudo-aglycone of actaplanin
US4322406A (en) * 1980-12-18 1982-03-30 Eli Lilly And Company Antibiotic A-4696 factors B1, B2, B3, C1a, C3 and E1

Also Published As

Publication number Publication date
FI834594A0 (fi) 1983-12-14
IL70441A0 (en) 1984-03-30
DK578083D0 (da) 1983-12-15
ATE42571T1 (de) 1989-05-15
JPH05168466A (ja) 1993-07-02
EP0112184B1 (en) 1989-04-26
IE56382B1 (en) 1991-07-17
NZ206592A (en) 1987-02-20
DK167688B1 (da) 1993-12-06
AU563466B2 (en) 1987-07-09
JPH0430400B2 (ko) 1992-05-21
ES8504935A1 (es) 1985-05-01
GR78784B (ko) 1984-10-02
IL70441A (en) 1986-11-30
ZA839269B (en) 1985-07-31
KR860001497B1 (ko) 1986-09-27
JPH0771479B2 (ja) 1995-08-02
FI834594L (fi) 1984-06-21
GB8333668D0 (en) 1984-01-25
RO87735A2 (ro) 1985-10-31
DD210709A1 (de) 1984-06-20
HU192971B (en) 1987-08-28
AU2242683A (en) 1984-06-28
RO87735B1 (ro) 1985-10-01
CA1214413A (en) 1986-11-25
EP0112184A3 (en) 1985-06-19
EP0112184A2 (en) 1984-06-27
SU1194285A3 (ru) 1985-11-23
DE3379735D1 (en) 1989-06-01
JPS59118798A (ja) 1984-07-09
PH20198A (en) 1986-10-16
GB2132207A (en) 1984-07-04
EG16163A (en) 1989-01-30
GB2132207B (en) 1986-06-04
PT77810A (en) 1984-01-01
DK578083A (da) 1984-06-21
HK72088A (en) 1988-09-16
IE832990L (en) 1984-06-20
ES528197A0 (es) 1985-05-01

Similar Documents

Publication Publication Date Title
KR860001110A (ko) 항균제 ⅱ의 제법
AU568513B2 (en) Beta-carbolines
KR840005483A (ko) A47934 항생물질의 제조방법
KR850004341A (ko) 표시관(表示管)
KR840007437A (ko) 항생제 a 51568 인자 a 및 b의 제조방법
KR830001993A (ko) 고농도 중합체 슬러리
KR870011153A (ko) 면역억제물질 시클로뎁시펩티드와 그의 제조방법
KR890008325A (ko) 아미노디옥시 만니톨의 제법
KR830002749A (ko) 부티로락톤의 제조방법
KR830005168A (ko) 5-(디하이드록시페녹시)테트라졸의 제조방법
KR830005360A (ko) 키자니마이신의 제조방법
SE8402619D0 (sv) Bbm-1675, a new antitumor antibiotic complex
KR850003411A (ko) 글리코펩타이드 바이오컨버전 생성물의 제조방법
KR830005357A (ko) 나라신의 제조방법
KR850008492A (ko) 트랜스, 트랜스-8,10-도데카디엔-1-일옥시실란의 제조방법
KR910003113A (ko) 항생물질 플러스박신
KR910012257A (ko) 벤즈안트라센 화합물 및 이의 제조방법
KR840008814A (ko) 콜레스테롤 산화효소의 제조방법
SU621723A1 (ru) Способ производства этилового спирта из крахмалосодержащего сырь
KR870008535A (ko) "밤"가루(율분)
IE45442L (en) 6ó-methoxy and 6-ketimino-penicillins
KR890008326A (ko) I-디옥시만노딜리마이신의 제법
KR880001213A (ko) 수중부착 생물방제제
KR850007199A (ko) 세우액젓을 주재로 한 인스탄트 젓갈의 제조방법
KR870008861A (ko) 트리아졸린-5-온 유도체의 제조방법

Legal Events

Date Code Title Description
A201 Request for examination
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19831220

PA0201 Request for examination
PG1501 Laying open of application
G160 Decision to publish patent application
PG1605 Publication of application before grant of patent

Comment text: Decision on Publication of Application

Patent event code: PG16051S01I

Patent event date: 19860830

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 19861210

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 19870108

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 19870108

End annual number: 3

Start annual number: 1

PR1001 Payment of annual fee

Payment date: 19890705

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 19900711

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 19910719

Start annual number: 6

End annual number: 6

PR1001 Payment of annual fee

Payment date: 19920706

Start annual number: 7

End annual number: 7

PR1001 Payment of annual fee

Payment date: 19930628

Start annual number: 8

End annual number: 8

PR1001 Payment of annual fee

Payment date: 19940616

Start annual number: 9

End annual number: 9

PR1001 Payment of annual fee

Payment date: 19950615

Start annual number: 10

End annual number: 10

FPAY Annual fee payment

Payment date: 19960628

Year of fee payment: 11

PR1001 Payment of annual fee

Payment date: 19960628

Start annual number: 11

End annual number: 11

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee